Amino-5-[substituted-4-(difluoromethoxy)phenyl]-5- phenylimidazolone compounds as ss-secretase inhibitors
A technology of difluoromethoxyl compounds applied to amino-5-[substituted-4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds as beta-secretase inhibitors field, it can solve the problems that cannot be predicted a priori, blocking hERG channels, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
example 1
[0348] Preparation of 2-amino-5-[4-(difluoromethoxy)-3-methylphenyl]-3-methyl-5-phenyl-3,5-dihydro-4H-imidazol-4-one
[0349]
[0350] Step 1: 1-(Difluoromethoxy)-4-iodo-2-methylbenzene
[0351] A mixture of 4-iodo-2-methylphenol (10 g, 42.7 mmol) in DMF and water was treated with 2-chloro-2,2-difluoroacetic acid (3.61 ml, 42.7 mmol) and potassium carbonate (23.62 g, 171 mmol) Worked up, heated to 120 °C for 12 hours, cooled to room temperature and diluted with EtOAc and water. The organic phase was separated, washed successively with water and brine, washed with Na 2 SO 4 Dry and concentrate in vacuo. The resulting residue was purified by flash chromatography (0-10% EtOAc / hexanes) to give 1-(difluoromethoxy)-4-iodo-2-methylbenzene (3 g, 10.56 mmol, 24.72 %Yield). 1 H NMR (400MHz, DMSO-d 6 )δ7.66(d, J=1.5Hz, 1H), 7.56(dd, J=8.47 and 2.09Hz, 1H), 7.15(t, J H-F =74Hz, 1H), 6.92(d, J=8.47Hz, 1H), 2.15(s, 3H).
[0352] Step 2: 1-(Difluoromethoxy)-2-methyl-4-(phenylethyn...
example 2
[0359] Preparation of (5S)-2-amino-5-[4-(difluoromethoxy)-3-methylphenyl]-3-methyl-5-phenyl-3,5-dihydro-4H-imidazole -4-keto[A] and (5R)-2-amino-5-[4-(difluoromethoxy)-3-methylphenyl]-3-methyl-5-phenyl-3,5 -Dihydro-4H-imidazol-4-one[B]
[0360]
[0361] 2-amino-5-[4-(difluoromethoxy)-3-methylphenyl]-3-methyl-5-phenyl-3,5-dihydro-4H-imidazol-4-one (1.8 g, 5.21 mmol) of the racemic mixture was separated by chiral chromatography (Chiral Cel OJ (Chiral Cel OJ) 5 x 50 cm, mobile phase 15% 2-butanol (0.1% DEA) in hexane) , the title product A (S-enantiomer) peak 1 was obtained as a white solid, RT = 8.5 min, (0.9 g, 2.61 mmol, 50.0% yield), MS m / e (M+H) + 346.10, [α] D 25 =+11.2 (c=1% in MeOH); and the title product B (R-enantiomer) peak 2 as a white solid, RT=11.8 min, (0.84 g, 2.432 mmol, 46.7% yield ), MS m / e(M+H) + 346.10, [α] D 25 = -9.2 (c = 1% in MeOH).
example 3
[0363] Preparation of 2-amino-4-(4-(difluoromethoxy)-3-methylphenyl)-4-(4-fluorophenyl)-1-methyl-1H-imidazole-5(4H)- ketone
[0364]
[0365] Step 1: {[4-(Difluoromethoxy)-3-methylphenyl]ethynyl}trimethylsilane
[0366] 4-Bromo-1-(difluoromethoxy)-2-methylbenzene (5.3g, 22.36mmol), ethynyltrimethylsilane (4.74ml, 33.5mmol) and triethylamine (15.58ml, 112mmol ) in DMF by adding N 2 Degas by bubbling for 30 min under constant N 2 Treat with bis(triphenylphosphine)dichloropalladium (0.785 g, 1.118 mmol) with bubbling, copper(I) iodide (0.426 g, 2.236 mmol), warm to 65°C for 12 hours, cool to room temperature , partitioned between ether and 2M HCl and filtered through Celite. The filtrate was separated and the organic phase was washed successively with 2M HCl and brine, washed with Na 2 SO 4 Dry and concentrate in vacuo. The resulting residue was purified by flash chromatography (100% hexanes) to give ((4-(difluoromethoxy)-3-methylphenyl)ethynyl)trimethylsilane (5.49 g, ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com